The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Kimberly Stegmaier was named chair of Pediatric Oncology at Dana-Farber Cancer Institute and associate chief of the Division of Hematology/Oncology at Boston Children’s Hospital. Her appointment is effective April 1.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Thyme Care triples multidisciplinary care team with increased focus on survivorship

Thyme Care expanded its survivorship program and comprehensive cancer care services with the appointment of two experienced medical directors: Asma Dilawari as medical director of oncology care, who will lead the company’s survivorship program expansion, and Nelia Jain as medical director of palliative care, who will scale Thyme Care’s virtual palliative care offering, called Enhanced Supportive Care. 
In Brief

Swim Across America grants $900,000 toward gene editing innovation

Joseph FraiettaPietro GenoveseSwim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, awarded $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies, and cellular therapies. 
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account